Despite sepsis being a life-threatening disease, targeted drugs that improve the therapy of affected patients are still lacking. Infants and adults differ in the maturity level of their immune system and this results in distinct reactions to Gram-negative bacteria. To study reactions of human immune cells in vivo, we used NOD scid gamma mice transplanted with human CD34 stem cells to engraft a functional human immune system. Human cells undergo differentiation and maturation in these mice after transplantation and, accordingly, animals were divided into two groups: 8-13 wk and 15-22 wk after transplantation. Endotoxemia was induced by injecting LPS. Six h later, mice were euthanized. In both groups, LPS stimulation induced a decrease of CD14 monocytes in peripheral blood, an up-regulation of activation markers on different cell subsets such as myeloid dendritic cells, and a release of the human cytokines TNF-α, IL-6 and IL-10. However, significant differences were detected with regard to the amounts of released cytokines, and 8-13-wk-old mice produced more IL-6, while PTX3 was mainly released by 15-22-wk-old animals. Thus, here we provide a potential model for preclinical research of sepsis in infants and adults.
After transplantation with human umbilical cord blood cells NOD-SCID IL2Rγ(null) rodents develop an human immune system which is characterized by the presence of B cells, T cells, monocytes, granulocytes and dendritic cells. The extent of the several subpopulations differs during the time after transplantation. A clear development of the immune system can be seen from immature immune system which contains mainly B cells, a few T cells in peripheral blood, during a transitional state with an additional existence of monocytes, granulocytes and denritic cells in bone marrow and spleen of the mice to a state which reminds of Graft-versus-Host-Disease. This development can be observed during a period of 10 to 20 weeks after transplantation. The B cells are able to produce high amounts of IgM in the early state and few IgG. The antigen presenting cells in the transitional state are able to express activation molecules like HLA-DR and CD86 after the injection of LPS as an immune modifying stimulus. Moreover the cells are able to produce human TNFα, IL-10, IL-1b, IFNγ and high amounts of IL-6 after stimulation with LPS in every state. Release of murine TNFα, IL10, IL-6, MCP and IL-12 was detected as well. The presence of human and murine PTX3 was also measureable after in vivo stimulation with LPS. Depending on the time point after transplantation the human immune cells are able to produce human cytokines and to express several activation markers after immune modifying stimulus.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.